Morris, M. J., Armstrong, A. J., Chi, K. N. N., de Bono, J. S., Herrmann, K., Krause, B., … Fizazi, K. (2023). 1810P Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer. In Annals of Oncology (Vol. 34, pp. S979–S980). Elsevier BV. https://doi.org/10.1016/j.annonc.2023.09.2758

Morris, M. J., A. J. Armstrong, K. N. N. Chi, J. S. de Bono, K. Herrmann, B. Krause, K. Rahbar, et al. “1810P Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer.” In Annals of Oncology, 34:S979–80. Elsevier BV, 2023. https://doi.org/10.1016/j.annonc.2023.09.2758.

Morris MJ, Armstrong AJ, Chi KNN, de Bono JS, Herrmann K, Krause B, et al. 1810P Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer. In: Annals of Oncology. Elsevier BV; 2023. p. S979–80.

Morris, M. J., et al. “1810P Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer.” Annals of Oncology, vol. 34, Elsevier BV, 2023, pp. S979–80. Crossref, doi:10.1016/j.annonc.2023.09.2758.

Morris MJ, Armstrong AJ, Chi KNN, de Bono JS, Herrmann K, Krause B, Rahbar K, Sartor O, Tagawa ST, Nagarajah J, Wei XX, Nordquist LT, Koshkin VS, Saad F, Vickers A, Ghouse R, Wu J, Mirante O, Fizazi K. 1810P Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer. Annals of Oncology. Elsevier BV; 2023. p. S979–S980.